explore -WSS

explore

author：knowledge 2025-08-26 01:32:48 - browse：69

Portrait of Don Davis -- health policy coverage from STAT — U.S. Representative Don Davis (D-N.C.) Wikimedia Commons

WASHINGTON — Two Republican lawmakers who introduced legislation to water down the Inflation Reduction Act’s Medicare drug price negotiation program managed to find themselves a Democratic co-sponsor — even though every single Democrat in Congress in 2022 voted for the legislation.

They found their perfect candidate in Rep. Don Davis, a Democrat representing a North Carolina district that includes parts of the state’s Research Triangle. He came to Washington in 2023, so didn’t vote on the original law. He received donations in 2023 from the political action committees for Gilead, Astellas, Genentech, Bayer, Pfizer, Novo Nordisk, GSK, Bristol Myers Squibb, BIO, Amgen, Boehringer Ingelheim, Merck, AbbVie, and Eli Lilly.

“We must support the development of critical, life-sustaining medical treatments and cures,” Davis said in a written statement, and a spokesperson declined to elaborate. He is joined on the bill by Rep. Greg Murphy (R-N.C.) and Brett Guthrie (R-Ky.), the Energy and Commerce health subcommittee chairman.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Senate committee scrutinizes Medicare Advantage brokers

WSS

Using force crossed my mind when examining a defiant young patient

Impact of Dobbs ruling felt at reproductive medicine meeting

FDA gives detailed accounting of AI

Laying a path for careers in science

Cholera vaccine supplies dangerously low, outbreaks surging

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

explore

explore

focus

Hollywood unions extend contract negotiations for actors

Doctor of U.S. President Joe Biden says he is fit for duty

United colonoscopy coverage change 'may cost lives,' doctors say

Using force crossed my mind when examining a defiant young patient

Peter Hotez and the public health issue of online harassment

Ohio train derailment: Experts on toxic chemical risks

Medical records are filled with copy

CEOs share strategies for surviving biotech slump

How one medical school became remarkably diverse

The EU Joint Clinical Assessment needs to live up to its promise

hotspot

Study fuels hope CAR

Studies point to risks of excluding people with obesity from drug trials

Medicare Advantage isn’t working — for anyone

Color Health wants to make cancer screenings convenient

CDC panel: People 65 and older should get a Covid spring booster shot

HHS leader on health, climate change and biopharma emissions

explore

explore

knowledge

hotspot